Crossmark

Feasibility of standalone antitubercular therapy for retinal vasculitis

Crossref DOI link: https://doi.org/10.1038/s41433-021-01910-6

Published Online: 2022-01-18

Published Print: 2022-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Shukla, Dhananjay https://orcid.org/0000-0002-6585-4969
License Information

Text and Data Mining valid from 2022-01-18

Version of Record valid from 2022-01-18
More Information

Article History

Received: 14 September 2021

Revised: 25 November 2021

Accepted: 15 December 2021

First Online: 18 January 2022

Competing interests

: The author declares no competing interests.